A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Clinical trial NCT07390383 · RECRUITING

Trial details

NCT number: NCT07390383
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumour

Start date: 2026-04-13
Primary completion: 2028-05-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.